CM

Chintan Manjibhai Vaghani

Active Director Designated Partner DIN 09236063
DIN 09236063 First appointment Jul 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Chintan Manjibhai Vaghani

Data last updated:

Chintan Manjibhai Vaghani is a Designated Partner at Chemneal Pharmaceuticals Llp (since 2021). The company operates in Chemicals.

DIN 09236063
Primary Designation Designated Partner
Industry Chemicals
First Appointment 12 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Jul 20212021Active

Board colleagues of Chintan Manjibhai Vaghani

Directorship timeline

Open interactive timeline →
Chemneal Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Chintan Manjibhai Vaghani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chintan Manjibhai Vaghani

Chintan Manjibhai Vaghani currently holds 1 directorship: Chemneal Pharmaceuticals Llp (Designated Partner, since 12 Jul 2021).

Chintan Manjibhai Vaghani was first appointed on 12 Jul 2021 as Designated Partner at Chemneal Pharmaceuticals Llp.

The current boards of Chintan Manjibhai Vaghani's companies include Hetalben Chintan Vaghani (Chemneal Pharmaceuticals Llp), Nileshkumar Batukbhai Vaghani (Chemneal Pharmaceuticals Llp), Shaileshkumar Batukbhai Vaghani (Chemneal Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available